Halozyme Therapeutics Inc
NASDAQ:HALO

Watchlist Manager
Halozyme Therapeutics Inc Logo
Halozyme Therapeutics Inc
NASDAQ:HALO
Watchlist
Price: 53.15 USD 0.08% Market Closed
Market Cap: 6.5B USD

Wall Street
Price Targets

HALO Price Targets Summary
Halozyme Therapeutics Inc

Wall Street analysts forecast HALO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HALO is 71.98 USD with a low forecast of 62.62 USD and a high forecast of 82.95 USD.

Lowest
Price Target
62.62 USD
18% Upside
Average
Price Target
71.98 USD
35% Upside
Highest
Price Target
82.95 USD
56% Upside
Halozyme Therapeutics Inc Competitors:
Price Targets
300601
Shenzhen Kangtai Biological Products Co Ltd
21% Upside
NBIX
Neurocrine Biosciences Inc
26% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
32% Upside
BAVA
Bavarian Nordic A/S
62% Upside
002252
Shanghai RAAS Blood Products Co Ltd
11% Upside
BEAM
Beam Therapeutics Inc
165% Upside
FLUO
Fluoguide AS
177% Upside
301080
Acrobiosystems Co Ltd
6% Upside

Revenue
Forecast

Revenue Estimate
Halozyme Therapeutics Inc

For the last 8 years the compound annual growth rate for Halozyme Therapeutics Inc's revenue is 27%. The projected CAGR for the next 3 years is 19%.

27%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Halozyme Therapeutics Inc

The compound annual growth rate of Halozyme Therapeutics Inc's operating income for the next 3 years is 26%.

N/A
Past Growth
26%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Halozyme Therapeutics Inc

The compound annual growth rate of Halozyme Therapeutics Inc's net income for the next 3 years is 34%.

N/A
Past Growth
34%
Estimated Growth
Estimates Accuracy
10%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HALO's stock price target?
Price Target
71.98 USD

According to Wall Street analysts, the average 1-year price target for HALO is 71.98 USD with a low forecast of 62.62 USD and a high forecast of 82.95 USD.

What is Halozyme Therapeutics Inc's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Halozyme Therapeutics Inc's revenue is 27%. The projected CAGR for the next 3 years is 19%.

What is Halozyme Therapeutics Inc's Operating Income forecast?
Projected CAGR
26%

The compound annual growth rate of Halozyme Therapeutics Inc's operating income for the next 3 years is 26%.

What is Halozyme Therapeutics Inc's Net Income forecast?
Projected CAGR
34%

The compound annual growth rate of Halozyme Therapeutics Inc's net income for the next 3 years is 34%.

Back to Top